Consumer Reports, October 31, 2019. Whether it be contaminated food, deadly infant sleepers, breast implants, or other unsafe products, recalls are not protecting us as well as they should be.
Read More »Tag: FDA
FDA calls for new warnings for breast implants
The Washington Post, October 23, 2019. Due to problems with breast implants, FDA calls for new warnings associated with the implants as well as providing more information about the devices.
Read More »Women Should Be Warned of Breast Implant Hazards, F.D.A. Says
NY Times, October 23, 2019. In light of breast implant hazards, FDA proposes that surgeons discuss the risks with patients and that manufacturers print bold warnings on the device packaging.
Read More »Breast implants, heavy metals & autoimmune disorders: What should be in FDA warnings?
AZ Family, October 18, 2019. As the FDA considers issuing stronger warnings on breast implants Dr. Diana Zuckerman explains the flaws in the original clinical trials.
Read More »NCHR Testimony on Singulair and Neuropsychiatric Side Effects
September 27, 2019. Singulair has serious side effects and we need much better data to determine the likely benefit and risk of harm for patients. FDA has an important role to play in encouraging this research. In the meantime, patients, parents, and clinicians must be given clear information about the risks so that they can make an informed decision about whether to use montelukast (Singulair).
Read More »